Romina Zarbl

707 total citations
19 papers, 397 citations indexed

About

Romina Zarbl is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Romina Zarbl has authored 19 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Immunology. Recurrent topics in Romina Zarbl's work include Epigenetics and DNA Methylation (11 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Immunotherapy and Immune Responses (7 papers). Romina Zarbl is often cited by papers focused on Epigenetics and DNA Methylation (11 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Immunotherapy and Immune Responses (7 papers). Romina Zarbl collaborates with scholars based in Germany, Australia and China. Romina Zarbl's co-authors include Dimo Dietrich, Glen Kristiansen, Emma Bawden, Jennifer Landsberg, Friedrich Bootz, Jörn Dietrich, Luka de Vos, Sebastian Strieth, Timo Vogt and Damian J. Ralser and has published in prestigious journals such as American Journal Of Pathology, Clinical Chemistry and Cancers.

In The Last Decade

Romina Zarbl

19 papers receiving 396 citations

Peers

Romina Zarbl
Jinyan Yang China
Wenyi Fan United States
Jari Karjalainen Finland
Jiang-Dong Sui China
Ruth A. White United States
Xiaoli Ji China
Sheryl Kunning United States
Marice Alcantara United States
Wendy Mao United States
Sadaf Mehdizadeh United States
Jinyan Yang China
Romina Zarbl
Citations per year, relative to Romina Zarbl Romina Zarbl (= 1×) peers Jinyan Yang

Countries citing papers authored by Romina Zarbl

Since Specialization
Citations

This map shows the geographic impact of Romina Zarbl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Romina Zarbl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Romina Zarbl more than expected).

Fields of papers citing papers by Romina Zarbl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Romina Zarbl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Romina Zarbl. The network helps show where Romina Zarbl may publish in the future.

Co-authorship network of co-authors of Romina Zarbl

This figure shows the co-authorship network connecting the top 25 collaborators of Romina Zarbl. A scholar is included among the top collaborators of Romina Zarbl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Romina Zarbl. Romina Zarbl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Vos, Luka de, Romina Zarbl, Judith Sirokay, et al.. (2024). Circulating Cell-Free SHOX2 DNA Methylation Is a Predictive, Prognostic, and Monitoring Biomarker in Adjuvant and Palliative Anti-PD-1-Treated Melanoma. Clinical Chemistry. 70(3). 516–527. 3 indexed citations
2.
Büttner, Thomas, Dimo Dietrich, Romina Zarbl, et al.. (2024). Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach. Cancers. 16(3). 482–482. 2 indexed citations
3.
Hoffmann, Friederike, Alina Franzen, Luka de Vos, et al.. (2023). CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma. Clinical Epigenetics. 15(1). 112–112. 15 indexed citations
4.
Ralser, Damian J., Luka de Vos, Romina Zarbl, et al.. (2023). ICOS DNA methylation regulates melanoma cell-intrinsic ICOS expression, is associated with melanoma differentiation, prognosis, and predicts response to immune checkpoint blockade. Biomarker Research. 11(1). 56–56. 4 indexed citations
5.
Klümper, Niklas, Damian J. Ralser, Romina Zarbl, et al.. (2023). PD-L1 ( CD274 ) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma. OncoImmunology. 12(1). 2267744–2267744. 1 indexed citations
6.
Hoffmann, Friederike, Anne Fröhlich, Judith Sirokay, et al.. (2023). DNA methylation of GITR, OX40, 4-1BB, CD27, and CD40 correlates with BAP1 aberrancy and prognosis in uveal melanoma. Melanoma Research. 33(2). 116–125. 3 indexed citations
7.
Dietrich, Dimo, Luka de Vos, Timo Vogt, et al.. (2023). Circulating Cell-Free SEPT9 DNA Methylation in Blood Is a Biomarker for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma Patients. Clinical Chemistry. 69(9). 1050–1061. 9 indexed citations
8.
9.
Vos, Luka de, Romina Zarbl, Niklas Klümper, et al.. (2022). CTLA4, PD-1, PD-L1, PD-L2, TIM-3, TIGIT, and LAG3 DNA Methylation Is Associated With BAP1-Aberrancy, Transcriptional Activity, and Overall Survival in Uveal Melanoma. Journal of Immunotherapy. 45(7). 324–334. 12 indexed citations
10.
11.
Tolkach, Yuri, Romina Zarbl, Manuel Ritter, et al.. (2021). DNA Promoter Methylation and ERG Regulate the Expression of CD24 in Prostate Cancer. American Journal Of Pathology. 191(4). 618–630. 10 indexed citations
12.
Ralser, Damian J., Niklas Klümper, Heidrun Gevensleben, et al.. (2021). Molecular and Immune Correlates of PDCD1 (PD-1), PD-L1 (CD274), and PD-L2 (PDCD1LG2) DNA Methylation in Triple Negative Breast Cancer. Journal of Immunotherapy. 44(8). 319–324. 15 indexed citations
13.
Zarbl, Romina, Dennis Niebel, Christian Posch, et al.. (2020). CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab). Cancer Immunology Immunotherapy. 70(6). 1781–1788. 22 indexed citations
14.
15.
Hoffmann, Friederike, Romina Zarbl, Dennis Niebel, et al.. (2020). Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma. Clinical Epigenetics. 12(1). 94–94. 28 indexed citations
16.
Klümper, Niklas, Damian J. Ralser, Emma Bawden, et al.. (2020). LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 8(1). e000552–e000552. 80 indexed citations
17.
Vos, Luka de, Emma Bawden, Jörn Dietrich, et al.. (2020). The landscape of CD28, CD80, CD86, CTLA4, and ICOS DNA methylation in head and neck squamous cell carcinomas. Epigenetics. 15(11). 1195–1212. 33 indexed citations
18.
Holderried, Tobias A.W., Luka de Vos, Emma Bawden, et al.. (2019). Molecular and immune correlates of TIM-3 (HAVCR2) and galectin 9 (LGALS9) mRNA expression and DNA methylation in melanoma. Clinical Epigenetics. 11(1). 161–161. 54 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinyan Yang Breakdown of academic impact, for papers by Wenyi Fan Breakdown of academic impact, for papers by Jari Karjalainen Breakdown of academic impact, for papers by Jiang-Dong Sui Breakdown of academic impact, for papers by Ruth A. White Breakdown of academic impact, for papers by Xiaoli Ji Breakdown of academic impact, for papers by Sheryl Kunning Breakdown of academic impact, for papers by Marice Alcantara Breakdown of academic impact, for papers by Wendy Mao Breakdown of academic impact, for papers by Sadaf Mehdizadeh
Rankless by CCL
2026